Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,221
Closed -$10K 2219
2023
Q3
$10K Sell
1,221
-16,579
-93% -$139K ﹤0.01% 2213
2023
Q2
$171K Sell
17,800
-3,493
-16% -$36.3K ﹤0.01% 1848
2023
Q1
$256K Buy
21,293
+1,108
+5% +$14.5K ﹤0.01% 1832
2022
Q4
$281K Buy
20,185
+1,056
+6% +$12.8K ﹤0.01% 1831
2022
Q3
$174K Sell
19,129
-3,788
-17% -$33.1K ﹤0.01% 1896
2022
Q2
$182K Buy
22,917
+3,401
+17% +$24.1K ﹤0.01% 1834
2022
Q1
$125K Hold
19,516
﹤0.01% 1950
2021
Q4
$177K Hold
19,516
﹤0.01% 1891
2021
Q3
$204K Hold
19,516
﹤0.01% 1897
2021
Q2
$274K Hold
19,516
﹤0.01% 1864
2021
Q1
$271K Sell
19,516
-2,202
-10% -$33.6K ﹤0.01% 1872
2020
Q4
$265K Sell
21,718
-2,457
-10% -$32K ﹤0.01% 1906
2020
Q3
$383K Buy
24,175
+2,834
+13% +$47.8K ﹤0.01% 1744
2020
Q2
$481K Buy
+21,341
New +$357K ﹤0.01% 1703

Other funds holding ZYXI

Canada Life's ZYXI Position: Q4 2023 in Review

Canada Life sold out of Zynex (ZYXI) in Q4 2023, closing a stake of 1,221 shares — an estimated $10K sold.

Canada Life first reported a position in ZYXI in Q2 2020 and held it in 14 quarters. The position peaked at $481K in Q2 2020. 113 funds tracked by Wall St. Rank hold ZYXI as of Q4 2023.

  • Canada Life reported no remaining Zynex position as of Q4 2023 after selling out during the quarter.
  • Canada Life sold 1,221 Zynex shares in Q4 2023, an estimated $10K.
  • Canada Life first reported a position in Zynex in Q2 2020 and held it in 14 quarters.
  • Canada Life's Zynex position peaked at $481K in Q2 2020.
  • 113 funds tracked by Wall St. Rank held Zynex as of Q4 2023.

Based on Canada Life's 13F filing for Q4 2023, filed 13 Feb 2024.